SCHEMBL4014093

SCHEMBL4014093

CCCCOC(=O)N1CCC(COC(C)c2cc(C)cc3cnn(CC(F)F)c23)(c2ccc(F)cc2)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 2/20 0.33
OPRK1 P41145 1/20 0.33
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32
CTSK P43235 1/20 0.32
TSHR P16473 3/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
TRPC6 Q9Y210 1/20 0.31
TACR1 P25103 2/20 0.31
SLC6A4 P31645 2/20 0.31
KCNH2 Q12809 2/20 0.31
MCHR1 Q99705 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2429711 0.88 TACR1 (0.33) TACR1SLC6A4KCNH2S1PR2
SCHEMBL2426754 0.87 TACR1 (0.39) POLBTACR1RORC
SCHEMBL3924879 0.86 CTSK (0.37) OPRD1OPRK1HRH2HRH1CTSK
SCHEMBL2424078 0.85 TACR1 (0.42) TACR1SLC6A4KCNH2
SCHEMBL2428531 0.79 MAPK1 (0.35) OPRD1TACR1SLC6A4KCNH2MAPK1
SCHEMBL2425751 0.79 CNR2 (0.37) POLBSMN1; SMN2TACR1
SCHEMBL2428029 0.76 TACR1 (0.37) TACR1SLC6A4KCNH2MAPK1
SCHEMBL12290476 0.75 CCR5 (0.39) POLBTACR1LMNAMAPT
SCHEMBL2429202 0.75 TACR1 (0.42) TACR1SLC6A4KCNH2
SCHEMBL2429704 0.73 ACACB (0.39) TACR1SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO disclosed